Concepedia

Mark D. Long

MD

48

Publications

2.3K

Citations

26

H-Index

2005

Active since

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Dana-Farber Cancer Institute

Cancer Genetics (United States)

Harvard University

The Ohio State University

Mark D. Long is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, tumor biology, and immunology.

ORCID

Top concepts

Publications per year

2005–2024

48

Publications

48

Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas

Spencer R. Rosario, Mark D. Long, Hayley C. Affronti et al. · Nature Communications · 2018 · 275 citations · Full text

, , +22

MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer

Yota Yasumizu, Hasan Rajabi, Caining Jin et al. · Nature Communications · 2020 · 191 citations · Full text

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

Takaaki Oba, Mark D. Long, Tibor Keler et al. · Nature Communications · 2020 · 126 citations · Full text

Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model

Johannes Gebert, Ozkan Gelincik, Mine Oezcan-Wahlbrink et al. · Gastroenterology · 2021 · 106 citations · Full text

Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation

Yixuan Zhou, Ingmar N. Bastian, Mark D. Long et al. · Proceedings of the National Academy of Sciences · 2021 · 96 citations · Full text

Rows per page

1–5 of 48